Integrated BioPharma (INBP) director reports 1.36M-share bona fide gifts

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Integrated BioPharma director and 10% owner William H. Milmoe reported two bona fide gifts of Common Stock made through entities he is associated with. On March 24, 2026, 1,356,293 shares were transferred from CD Financial, LLC to CDDS 2.0, LLC, and 7,392 shares were transferred from the Carl DeSantis Revocable Trust to the same LLC controlled by Damon DeSantis. These are non-cash, indirect transfers rather than market sales. After the gifts, Milmoe’s reported holdings across CD Financial, the revocable trust, the Estate of Carl DeSantis, and his direct ownership total 11,505,340 shares of Integrated BioPharma Common Stock.

Insider Trade Summary

1,363,685 shares gifted

Mixed 2 txns

Insider Milmoe William H.

Role Director, 10% Owner

Type	Security	Shares	Price	Value
Gift	Common Stock	1,356,293	$0.00	--
Gift	Common Stock	7,392	$0.00	--

Holdings After Transaction: Common Stock — 11,512,732 shares (Indirect, Trustee or Officer)

Footnotes (1)

Represents 1,356,293 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis. Includes 9,116,547 shares of Common Stock owned by CD Financial, LLC, 2,242,809 shares of Common Stock owned by the Carl DeSantis Revocable Trust, 14,709 shares of Common Stock owned by the Estate of Carl DeSantis and 138,667 owned by the Reporting Person directly. Represents 7,392 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis. Includes 9,116,547 shares of Common Stock owned by CD Financial, LLC, 2,235,417 shares of Common Stock owned by the Carl DeSantis Revocable Trust, 14,709 shares of Common Stock owned by the Estate of Carl DeSantis and 138,667 owned by the Reporting Person directly.

Form 4 Insider Transactions: What Each Field Means →

03/25/2026 - 05:26 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Milmoe William H.

(Last)

(First)

(Middle)

109 SE 5TH AVENUE

SECOND FLOOR

(Street)

DELRAY BEACH

FLORIDA

33483

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INTEGRATED BIOPHARMA INC [ INBP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/24/2026		G		1,356,293⁽¹⁾	D	$0	11,512,732⁽²⁾	I	Trustee or Officer
Common Stock	03/24/2026		G		7,392⁽³⁾	D	$0	11,505,340⁽⁴⁾	I	Trustee or Officer

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents 1,356,293 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.

2. Includes 9,116,547 shares of Common Stock owned by CD Financial, LLC, 2,242,809 shares of Common Stock owned by the Carl DeSantis Revocable Trust, 14,709 shares of Common Stock owned by the Estate of Carl DeSantis and 138,667 owned by the Reporting Person directly.

3. Represents 7,392 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.

4. Includes 9,116,547 shares of Common Stock owned by CD Financial, LLC, 2,235,417 shares of Common Stock owned by the Carl DeSantis Revocable Trust, 14,709 shares of Common Stock owned by the Estate of Carl DeSantis and 138,667 owned by the Reporting Person directly.

	/s/ William Milmoe	03/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did INBP director William H. Milmoe report?

William H. Milmoe reported two bona fide gifts of Integrated BioPharma Common Stock. One gift involved 1,356,293 shares and the other 7,392 shares, both transferred indirectly through entities he is associated with, rather than through open-market sales.

How many INBP shares did William H. Milmoe gift in this Form 4?

Milmoe reported gifting a total of 1,363,685 Integrated BioPharma shares. This includes 1,356,293 shares from CD Financial, LLC and 7,392 shares from the Carl DeSantis Revocable Trust, both transferred to CDDS 2.0, LLC as bona fide gifts.

Who received the gifted Integrated BioPharma (INBP) shares?

The gifted Integrated BioPharma shares were transferred to CDDS 2.0, LLC. One block came from CD Financial, LLC and another from the Carl DeSantis Revocable Trust, with CDDS 2.0, LLC described as a Florida limited liability company controlled by Damon DeSantis.

Are William H. Milmoe’s INBP transactions market sales or non-cash gifts?

The reported Integrated BioPharma transactions are non-cash bona fide gifts, not market sales. Both entries use transaction code “G” for gifts, with a price per share of $0.00, indicating transfers of ownership without sale proceeds changing hands.

How many INBP shares does William H. Milmoe report owning after the gifts?

After the reported gifts, Milmoe reports beneficial ownership of 11,505,340 Integrated BioPharma shares. This total spans CD Financial, LLC, the Carl DeSantis Revocable Trust, the Estate of Carl DeSantis, and 138,667 shares listed as owned directly by Milmoe.

Through which entities does William H. Milmoe hold his INBP stake?

Milmoe’s reported Integrated BioPharma stake is mainly indirect. It includes shares owned by CD Financial, LLC, the Carl DeSantis Revocable Trust, and the Estate of Carl DeSantis, plus 138,667 shares owned directly, according to the beneficial ownership breakdown in the footnotes.